Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Concord Medical Announces the Successful Holding of the Second Annual Academic Meeting with the world well-known MD Anderson 2022-11-16 20:55
Xiantao Zhengxin Group Introduces a Fully Automated Mask Production Line to Expand Production Capacity, Reduce Pollution and Contribute to Sustainable Development 2022-11-16 11:56
Simcere and Idorsia enter into a licensing agreement for daridorexant in China 2022-11-16 08:32
Island to present at World Antiviral Congress 2022 2022-11-15 21:00
Reistone Biopharma's oral Ivarmacitinib Meets Primary Endpoint in Phase III Study for Atopic Dermatitis 2022-11-15 21:00
HanAll Biopharma Reports Third Quarter 2022 Results and Provides Business Update 2022-11-15 20:00
Daewoong Pharmaceutical Surpasses KRW 300 Billion in Q3 Revenue as Nabota Sales Grew by 93%, Leading Overall Growth in Revenue 2022-11-15 20:00
EDAN Took Its Solutions up a Notch at MEDICA 2022 2022-11-15 18:26
Nona Biosciences Announces Attendance at PEGS Europe 2022 2022-11-15 15:57
WuXi Vaccines Establishes New Vaccines CDMO Facility in China 2022-11-15 12:45
HARBOUR BIOMED LAUNCHES NONA BIOSCIENCES' "IDEAS TO IND" PRECLINICAL SOLUTIONS BUSINESS TO ACCELERATE GLOBAL BIOTHERAPEUTIC INNOVATION 2022-11-15 12:19
Biotheus has entered into a license and collaboration agreement with Hansoh Pharma for its EGFR/MET bispecific antibody in the Greater China territory 2022-11-15 11:16
AIRS Medical showcases award-winning MRI enhancement AI solution at RSNA 2022 2022-11-14 23:00
The World's First ETa-specific Monoclonal Antibody: Gmax Biopharm's GMA131 Approved by the US FDA for Clinical Study on (DKD) Diabetic Kidney Disease 2022-11-14 22:55
Meihua International Medical Technologies Co., Limited Reports Unaudited 2022 First Half Financial Results 2022-11-14 21:00
Nuance Pharma Announces Clearance of IND Application for Respiratory Syncytial Virus (RSV) Vaccine in China 2022-11-14 09:54
Akeso's Ivonescimab (PD-1/VEGF Bispecific Antibody, AK112) Granted Breakthrough Therapy Designation for I-O Resistance NSCLC Patients in China 2022-11-14 08:00
SK Biopharmaceuticals Receives Korea Drug Development Fund Investment Grant to Develop Novel Oncology Candidate, SKL27969 2022-11-14 08:00
CHOCOLATE TOUCH®, NEXT-GENERATION DRUG-COATED ANGIOPLASTY BALLOON FOR THE TREATMENT OF PERIPHERAL ARTERIAL DISEASE RECEIVES FDA APPROVAL 2022-11-11 14:00
J INTS BIO, Novel Oral 4th Generation EGFR TKI 'JIN-A02' - Phase 1/2 IND approved by US FDA 2022-11-11 10:30
1 104 105 106 107 108 432